---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-101595"
form_type: "8-K"
ticker: null
cik: "0001173281"
company_name: "NeuBase Therapeutics, Inc."
filed_at: "2023-09-18T23:59:59+00:00"
generated_at: "2026-06-10T14:30:33.340759+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# NeuBase Therapeutics lowers stockholder meeting quorum to one-third of shares

## Summary
- Board approved bylaw amendment effective September 15, 2023.
- Quorum changed to one-third of shares outstanding and entitled to vote.
- Amendment intended to improve ability to hold stockholder meetings.

## SEC filing metadata
- accession: 0001104659-23-101595
- form_type: 8-K
- cik: 0001173281
- company_name: NeuBase Therapeutics, Inc.
- filed_at: 2023-09-18T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1173281/000110465923101595/0001104659-23-101595-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1173281/000110465923101595/tm2326323d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-101595
- JSON: https://secwatch.observer/filing/0001104659-23-101595.json
- Plain text: https://secwatch.observer/filing/0001104659-23-101595.txt

## Key facts
- Governance Changes
  NeuBase Therapeutics, Inc.: Changed quorum requirement for stockholder meetings to one-third of outstanding shares entitled to vote (effective 2023-09-15).
  - Change: bylaw amendment
  - Effective: 2023-09-15
  source text: On September 15, 2023, the Board of Directors of NeuBase Therapeutics, Inc. (the “Company”) approved an amendment of the Company’s Amended and Restated Bylaws (the “Bylaws”), effective as of September 15, 2023, to change the quorum for the transaction of business at stockholder meetings to one-third of the shares of stock outstanding and entitled to vote at the meeting.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1173281/000110465923101595/0001104659-23-101595-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.